BACKGROUND: In resource-limited settings, decentralization of HIV care and treatment is a cornerstone of universal care and rapid scale-up. We compared trends in pediatric enrollment and outcomes at primary (PHFs) vs secondary/tertiary health facilities (SHFs). METHODS: Using aggregate program data reported quarterly from 274 public facilities in Kenya, Lesotho, Mozambique, Rwanda, and Tanzania from January 2008 to March 2010, we examined trends in number of children younger than 15 years of age initiating antiretroviral treatment (ART) by facility type. We compared clinic-level lost to follow-up (LTFU) and mortality per 100 person-years (PYs) on ART during the period by facility type. RESULTS: During the 2-year period, 17,155 children enrolled in HIV care and 8475 initiated ART in 182 (66%) PHFs and 92(34%) SHFs. PHFs increased from 56 to 182, whereas SHFs increased from 72 to 92 sites. SHFs accounted for 71% of children initiating ART; however, the proportion of children initiating ART each quarter at PHFs increased from 17% (129) to 44% (463) in conjunction with an increase in PHFs during observation period. The average LTFU and mortality rates for children on ART were 9.8/100 PYs and 5.2/100 PYs, respectively, at PHFs and 20.2/100 PYs and 6.0/100 PYs, respectively, at SHFs. Adjusted models show PHFs associated with lower LTFU (adjusted rate ratio = 0.55; P = 0.022) and lower mortality (adjusted rate ratio = 0.66; P = 0.028). CONCLUSIONS: The expansion of pediatric services to PHFs has resulted in increased numbers of children on ART. Early findings suggest lower rates of LTFU and mortality at PHFs. Successful scale-up will require further expansion of pediatric services within PHFs.
BACKGROUND: In resource-limited settings, decentralization of HIV care and treatment is a cornerstone of universal care and rapid scale-up. We compared trends in pediatric enrollment and outcomes at primary (PHFs) vs secondary/tertiary health facilities (SHFs). METHODS: Using aggregate program data reported quarterly from 274 public facilities in Kenya, Lesotho, Mozambique, Rwanda, and Tanzania from January 2008 to March 2010, we examined trends in number of children younger than 15 years of age initiating antiretroviral treatment (ART) by facility type. We compared clinic-level lost to follow-up (LTFU) and mortality per 100 person-years (PYs) on ART during the period by facility type. RESULTS: During the 2-year period, 17,155 children enrolled in HIV care and 8475 initiated ART in 182 (66%) PHFs and 92(34%) SHFs. PHFs increased from 56 to 182, whereas SHFs increased from 72 to 92 sites. SHFs accounted for 71% of children initiating ART; however, the proportion of children initiating ART each quarter at PHFs increased from 17% (129) to 44% (463) in conjunction with an increase in PHFs during observation period. The average LTFU and mortality rates for children on ART were 9.8/100 PYs and 5.2/100 PYs, respectively, at PHFs and 20.2/100 PYs and 6.0/100 PYs, respectively, at SHFs. Adjusted models show PHFs associated with lower LTFU (adjusted rate ratio = 0.55; P = 0.022) and lower mortality (adjusted rate ratio = 0.66; P = 0.028). CONCLUSIONS: The expansion of pediatric services to PHFs has resulted in increased numbers of children on ART. Early findings suggest lower rates of LTFU and mortality at PHFs. Successful scale-up will require further expansion of pediatric services within PHFs.
Authors: Michelle S McConnell; Robert H Byers; Toni Frederick; Vicki B Peters; Kenneth L Dominguez; Thom Sukalac; Alan E Greenberg; Ho-Wen Hsu; Tamara A Rakusan; Idith R Ortiz; Sharon K Melville; Mary Glenn Fowler Journal: J Acquir Immune Defic Syndr Date: 2005-04-01 Impact factor: 3.731
Authors: Brian Eley; Mary-Ann Davies; Patti Apolles; Carol Cowburn; Heloise Buys; Marco Zampoli; Heather Finlayson; Spasina King; James Nuttall Journal: S Afr Med J Date: 2006-09
Authors: JoAnna K Leyenaar; Paul M Novosad; Katheleen T Ferrer; Lineo K Thahane; Edith Q Mohapi; Gordon E Schutze; Mark W Kline Journal: Pediatr Infect Dis J Date: 2010-04 Impact factor: 2.129
Authors: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245
Authors: Anand Reddi; Sarah C Leeper; Anneke C Grobler; Rosemary Geddes; K Holly France; Gillian L Dorse; Willem J Vlok; Mbali Mntambo; Monty Thomas; Kristy Nixon; Helga L Holst; Quarraisha Abdool Karim; Nigel C Rollins; Hoosen M Coovadia; Janet Giddy Journal: BMC Pediatr Date: 2007-03-17 Impact factor: 2.125
Authors: Daniel Cobos Muñoz; Paloma Merino Amador; Laura Monzon Llamas; David Martinez Hernandez; Juana Maria Santos Sancho Journal: Int J Public Health Date: 2016-08-29 Impact factor: 3.380
Authors: Shaffiq M Essajee; Stephen M Arpadi; Eric J Dziuban; Raul Gonzalez-Montero; Shirin Heidari; David G Jamieson; Scott E Kellerman; Emilia Koumans; Atieno Ojoo; Emilia Rivadeneira; Stephen A Spector; Helena Walkowiak Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Jan Ostermann; Kathryn Whetten; Elizabeth Reddy; Brian Pence; Andrew Weinhold; Dafrosa Itemba; Venance Maro; Eligy Mosille; Nathan Thielman Journal: AIDS Care Date: 2014-02-11
Authors: Nora M McCormick; Nan Li; David Sando; Aisa Muya; Karim P Manji; Rodrick Kisenge; Christopher Duggan; Guerino Chalamilla; Wafaie W Fawzi; Donna Spiegelman Journal: J Acquir Immune Defic Syndr Date: 2015-11-01 Impact factor: 3.731